102 related articles for article (PubMed ID: 19108617)
21. Antithyrotropin antibodies in the sera of Graves' disease patients.
Raines KB; Baker JR; Lukes YG; Wartofsky L; Burman KD
J Clin Endocrinol Metab; 1985 Aug; 61(2):217-22. PubMed ID: 2989314
[TBL] [Abstract][Full Text] [Related]
22. Thyroid-stimulating monoclonal antibodies.
Sanders J; Jeffreys J; Depraetere H; Richards T; Evans M; Kiddie A; Brereton K; Groenen M; Oda Y; Furmaniak J; Rees Smith B
Thyroid; 2002 Dec; 12(12):1043-50. PubMed ID: 12593717
[TBL] [Abstract][Full Text] [Related]
23. A novel hypothesis for the etiology of Graves' disease: TSAb may be thyroid stimulating animal IgG-like hormone and TBAb may be the precursor of TSAb.
Ochi Y; Kajita Y; Hachiya T; Hamaoki M
Med Hypotheses; 2012 Jun; 78(6):781-6. PubMed ID: 22472575
[TBL] [Abstract][Full Text] [Related]
24. Identification of the peptides that inhibit the stimulation of thyrotropin receptor by Graves' immunoglobulin G from peptide libraries.
Park JY; Kim IJ; Lee MH; Seo JK; Suh PG; Cho BY; Ryu SH; Chae CB
Endocrinology; 1997 Feb; 138(2):617-26. PubMed ID: 9002995
[TBL] [Abstract][Full Text] [Related]
25. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins.
Auf'mkolk M; Ingbar JC; Kubota K; Amir SM; Ingbar SH
Endocrinology; 1985 May; 116(5):1687-93. PubMed ID: 2985357
[TBL] [Abstract][Full Text] [Related]
26. Estimation of serum TSH receptor autoantibody concentration and affinity.
Nakatake N; Sanders J; Richards T; Burne P; Barrett C; Pra CD; Presotto F; Betterle C; Furmaniak J; Smith BR
Thyroid; 2006 Nov; 16(11):1077-84. PubMed ID: 17123333
[TBL] [Abstract][Full Text] [Related]
27. Identification of the peptides that inhibit the function of human monoclonal thyroid-stimulating antibodies from phage-displayed peptide library.
Byun CH; Park JY; Akamizu T; Chae CB
J Clin Endocrinol Metab; 2001 Jul; 86(7):3311-8. PubMed ID: 11443206
[TBL] [Abstract][Full Text] [Related]
28. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
Hill BL; Erlanger BF
Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
[TBL] [Abstract][Full Text] [Related]
30. Effects of TSH receptor mutations on binding and biological activity of monoclonal antibodies and TSH.
Sanders J; Bolton J; Sanders P; Jeffreys J; Nakatake N; Richards T; Evans M; Kiddie A; Summerhayes S; Roberts E; Miguel RN; Furmaniak J; Smith BR
Thyroid; 2006 Dec; 16(12):1195-206. PubMed ID: 17199429
[TBL] [Abstract][Full Text] [Related]
31. A sensitive and practical assay for thyroid-stimulating antibodies using crude immunoglobulin fractions precipitated with polyethylene glycol.
Kasagi K; Konishi J; Arai K; Misaki T; Iida Y; Endo K; Torizuka K
J Clin Endocrinol Metab; 1986 May; 62(5):855-62. PubMed ID: 2870075
[TBL] [Abstract][Full Text] [Related]
32. Molecular analysis of stimulatory anti-thyrotropin receptor antibodies (TSAbs) involved in Graves' disease. Isolation and reconstruction of antibody genes, and production of monoclonal TSAbs.
Akamizu T; Matsuda F; Okuda J; Li H; Kanda H; Watanabe T; Honjo T; Mori T
J Immunol; 1996 Oct; 157(7):3148-52. PubMed ID: 8816426
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function.
Sanders J; Jeffreys J; Depraetere H; Evans M; Richards T; Kiddie A; Brereton K; Premawardhana LD; Chirgadze DY; Núñez Miguel R; Blundell TL; Furmaniak J; Rees Smith B
Thyroid; 2004 Aug; 14(8):560-70. PubMed ID: 15320966
[TBL] [Abstract][Full Text] [Related]
34. Limitations of the semisynthetic library approach for obtaining human monoclonal autoantibodies to the thyrotropin receptor of Graves' disease.
Van Der Heijden JH; De Bruin TW; Glaudemans KA; De Kruif J; Banga JP; Logtenberg T
Clin Exp Immunol; 1999 Nov; 118(2):205-12. PubMed ID: 10540180
[TBL] [Abstract][Full Text] [Related]
35. Studies of possible antiidiotypic control mechanisms in Graves' disease.
Moynier M; Montano J; Williams RC; Pathak D; DeGroot LC; Hill BL; Marshall NJ
J Lab Clin Med; 1988 Jul; 112(1):99-108. PubMed ID: 2839588
[TBL] [Abstract][Full Text] [Related]
36. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
[TBL] [Abstract][Full Text] [Related]
37. Influences of cholera toxin on thyroid stimulation by thyrotropin and thyroid-stimulating antibody.
Zakarija M; McKenzie JM
Endocrinology; 1980 Dec; 107(6):2051-4. PubMed ID: 6107244
[TBL] [Abstract][Full Text] [Related]
38. TSBAb (TSH-stimulation blocking antibody) and TSAb (thyroid stimulating antibody) in TSBAb-positive patients with hypothyroidism and Graves' patients with hyperthyroidism.
Takasu N; Yamashiro K; Ochi Y; Sato Y; Nagata A; Komiya I; Yoshimura H
Horm Metab Res; 2001 Apr; 33(4):232-7. PubMed ID: 11383928
[TBL] [Abstract][Full Text] [Related]
39. Modulation of Fas-mediated apoptosis of human thyroid epithelial cells by IgG from patients with Graves' disease (GD) and idiopathic myxoedema.
Kawakami A; Eguchi K; Matsuoka N; Tsuboi M; Urayama S; Kawabe Y; Tahara K; Ishikawa N; Ito K; Nagataki S
Clin Exp Immunol; 1997 Dec; 110(3):434-9. PubMed ID: 9409648
[TBL] [Abstract][Full Text] [Related]
40. Graves' IgG stimulation of iodide uptake in FRTL-5 rat thyroid cells: a clinical assay complementing FRTL-5 assays measuring adenylate cyclase and growth-stimulating antibodies in autoimmune thyroid disease.
Marcocci C; Valente WA; Pinchera A; Aloj SM; Kohn LD; Grollman EF
J Endocrinol Invest; 1983 Dec; 6(6):463-71. PubMed ID: 6689493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]